×
×

Report

2023

2023-01-19 14:40 Torbjörn Sköld Appointed New CEO of Stille AB Regulatory MAR
Stille AB (publ) announces the board of director’s decision to appoint Torbjörn Sköld as the new CEO of Stille AB. Torbjörn Sköld has long experience from leading positions where the last 20 years have been within Life science with a primary focus on orthopedics and neurosurgery. The board of directors sees Torbjörns background and experience as great value, and he is well-suited to further...

2022

2022-10-27 08:00 Stille AB: Interim Report Q3 2022 Regulatory MAR
Stille AB (publ) publishes the interim report for the third quarter of 2022. ”The first three quarters of this year has displayed significant growth coupled with solid profitability. The third quarter continued the positive trend achieved during previous quarters this year”, says Hanna Ernestam Wilkman, Stille’s CEO.
2022-07-15 08:00 Stille AB: Interim Report Q2 2022 Regulatory MAR
Stille AB (publ) publishes the interim report for the second quarter and first half-year of 2022. ”Strong growth and significantly improved profits.”, summarizes Hanna Ernestam Wilkman, Stille’s CEO.
2022-04-28 08:00 Stille AB: Interim Report Q1 2022 Regulatory MAR
Stille AB (publ) publishes the report for the first quarter of 2022. ”A record breaking first quarter coupled with a high profitability.”, summarizes Stille CEO Hanna Ernestam Wilkman.
2022-03-31 08:00 Stille AB: Annual Report 2021 Regulatory
Stille AB (publ) today publishes the Annual Report for 2021.
2022-02-17 08:00 Stille AB: Year-End Report 2021 Regulatory MAR
Stille AB (publ) publishes the report for the fourth quarter and the full year of 2021. ”Strong sales despite current market situation”, summarizes Stille CEO Hanna Ernestam Wilkman.
Stille AB (publ) announces the appointment of Synovis Micro Companies Alliance, Inc,. as its exclusive distributor of surgical instruments in the United States.

2021

2021-10-27 08:00 Stille AB: Interim Report Q3 2021 Regulatory MAR
Stille AB (publ) publishes the report for the third quarter. “A quarter with strong growth”, summarizes CEO Hanna Ernestam Wilkman.
Stille AB (publ) announces exclusive collaboration with GE Healthcare for a new general surgery table in the United States.
2021-07-16 08:00 Stille AB: Interim Report Q2 2021 Regulatory MAR
Stille AB (publ) publishes the report for the second quarter and first half of 2021. “A historically strong second quarter with growth in all markets which we operate”, comments CEO Hanna Ernestam Wilkman.